Consequently, previous observations became explainable, such as when c-Myc-retransformed breast cancer tissues were found to contain substantial levels of 2HG (1–20 nmol/mg, i.e., up to ∼20 mM) in the absence of IDH1/2 mutations (168). This evidence concerns the gene IDH1 and breast cancer.